Avid Bioservices Inc (CDMO)

[biopharm]

Let's recap ...who is leading the Immunoscore project and working with biomarkers with Peregrine?

Bernard Fox via Jerome Galon

...Cliff Hoyt and Lisa Stepp ... Nikoletta Kallinteris etc

How the world turns

______

March 22, 2019

Commercial launch of CODEX® System and Phenoptics™ 2.0 provide the most complete suite of tools for tissue biomarker discovery and translationSpatially resolved, multiplexed tissue imaging can unravel the complexities of the tumor microenvironment

...
...


Bernard Fox, PhD, at the Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center was one of the first researchers to apply the MOTiF technology to his studies.“With the advancement of so many new therapeutic options, it’s imperative that we address the critical need for identifying the right biomarkers to improve treatment outcomes for cancer patients,” he said. “The addition of MOTiF technology to Phenoptics now provides us the right platform that can help generate large-scale clinical trial data for the validation of new biomarkers. Our experience with the implementation of this technology makes me optimistic that we will soon have a solution to better stratify patients for clinical trials and ultimately provide tailored therapy that will result in improved patient outcomes.”

“Akoya is excited to bring unprecedented power, scale, and automation to histology through the power of multiplex immunofluorescence,” said Brian McKelligon, Chief Executive Officer of Akoya. “The commercial availability of CODEX is a major achievement for Akoya and the release of Phenoptics 2.0 underscores the successful and rapid integration of the Phenoptics division from PerkinElmer into Akoya. We are proud to establish our market leadership in high-parameter tissue analysis with these transformative tools and to catalyze scientists’ ability to identify predictive biomarkers.”

https://www.marketwatch.com/press-release/akoya-biosciences-launches-comprehensive-solution-for-high-parameter-tissue-analysis-2019-03-22